CAS: 1676-57-9 - 5-BROMO-2-METHYL-4(1H)-PYRIMIDINONE
Formula:C5H5BrN2O
InChI:InChI=1/C5H5BrN2O/c1-3-7-2-4(6)5(9)8-3/h2H,1H3,(H,7,8,9)
- Synonyms:
- 4-Pyrimidinol, 5-Bromo-2-Methyl-
- 5-Bromo-2-methylpyrimidin-4-ol
- 5-Bromo-4-hydroxy-2-methylpyrimidine
- 5-bromo-2-methylpyrimidin-4(3H)-one
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 4(3H)-Pyrimidinone, 5-bromo-2-methyl- REF: IN-DA001XH1CAS: 1676-57-9 | 96% | 27.00 €~543.00 € | Tue 10 Dec 24 |
 | 5-Bromo-4-hydroxy-2-methylpyrimidine REF: 54-OR902451CAS: 1676-57-9 | 97+% | 32.00 €~2,421.00 € | Tue 17 Dec 24 |
 | 5-Bromo-4-hydroxy-2-methylpyrimidine REF: 3D-FB46167CAS: 1676-57-9 | Min. 95% | To inquire | Tue 21 Jan 25 |
 | 5-Bromo-4-hydroxy-2-methylpyrimidine REF: 10-F078816CAS: 1676-57-9 | 95.0% | - - - | Discontinued product |
4(3H)-Pyrimidinone, 5-bromo-2-methyl-
CAS:1676-57-9
Formula:
C5H5BrN2O
Purity:
96%
Color and Shape:
Solid
Molecular weight:
189.0100
Ref: IN-DA001XH1
| 1g | 63.00 € | ||
| 5g | 173.00 € | ||
| 10g | 233.00 € | ||
| 25g | 543.00 € | ||
| 100mg | 27.00 € | ||
| 250mg | 34.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 54-OR902451
| 1g | 40.00 € | ||
| 5g | 164.00 € | ||
| 25g | 673.00 € | ||
| 100g | 2,421.00 € | ||
| 250mg | 32.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
5-Bromo-4-hydroxy-2-methylpyrimidine
CAS:1676-57-9
Please enquire for more information about 5-Bromo-4-hydroxy-2-methylpyrimidine including the price, delivery time and more detailed …
Formula:
C5H5BrN2O
Purity:
Min. 95%
Molecular weight:
189.01 g/mol
Ref: 3D-FB46167
| 1g | To inquire | ||
| 2g | To inquire | ||
| 5g | To inquire | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
5-Bromo-4-hydroxy-2-methylpyrimidine
CAS:1676-57-9
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
189.01199340820312
Ref: 10-F078816
| 1g | Discontinued | Request information | |
| 5g | Discontinued | Request information | |
| 10g | Discontinued | Request information |
